Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-22

Clinical Trial Update: BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours [Phase 1]

View source ↗

Summary

Phase 1 study assessing the combination of afatinib (BIBW 2992) and vinorelbine in Japanese patients with advanced solid tumors; the trial is completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Afatinib (afatinib)
  • Vinorelbine (Navelbine) (vinorelbine tartrate)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Neoplasms | Phase 1 | Status: COMPLETED | Results posted: 2014-07-22